期刊文献+

吗啡控释片与芬太尼透皮贴剂治疗癌痛的疗效分析 被引量:16

A comparison between controlled-release morphine and transdennai fetauyl in the treatment of cancer pain
下载PDF
导出
摘要 目的:比较分析吗啡控释片与芬太尼透皮贴剂两种药物治疗癌痛的疗效与不良反应。方法:将130例中重度癌痛患者随机分成A、B两组,每组65例。A组使用芬太尼贴剂治疗癌痛,B组使用吗啡控释片治疗癌痛,比较两组的疗效和不良反应情况。结果:芬太尼贴剂总缓解率为89.2%,吗啡控释片的总缓解率为90.8%,两者差异无统计学意义;在本研究中的各种不良反应方面,A组不良反应发生率低于B组,差异均有统计学意义。结论:芬太尼透皮贴剂和口服吗啡控释片均可以有效地缓解中重度癌痛且两者疗效相近;除瘙痒外,芬太尼透皮贴剂不良反应的发生率均较低。 Objective:To research the effects and side effects of oral controlled-release morphine and transdennai fetauyl in the treatment of cancer pain.Methods:One hundred and thirty patients with cancer pain were randomly divided into two groups.A group was treated with transdennai fetauyl,and B group was treated with oral controlled-release morphine.The therapeutic efficacy and adverse reaction were observed and recorded.Results:The overall response ratesin group A and group B were 89.2% and 90.8%(P0.05).The side effects rate in group A was lower than that in group B(P0.05).Conclusion:The therapeutic efficacy of the transdennai fetauyl and oral controlled-release morphine is similar.Transdennai fetauyl is safer and more convenient than oral controlled-release morphine.
作者 阮玫
出处 《中国医药导报》 CAS 2011年第20期117-119,共3页 China Medical Herald
关键词 芬太尼贴剂 吗啡控释片 癌痛 恶性肿瘤 Transdennai fetauyl Controlled-release morphine Cancer pain Cancer
  • 相关文献

参考文献10

  • 1World Health Organization.Cancer Pain Relief:with a Guide to Opioid Availability[M].Seeond Edition.Geneva:World Health Organization,1996: 1-69.
  • 2Indelieato RA,Poaenoy RK.Opioid rotation in the management of refrac- tory cancer pain[J].J Clin 0ncol,2002,20(1):348-352.
  • 3Riley J,Ross JR,Rutter D,et al.No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alter- native opioid in cancer patients[J].Support Care Cancer,2006,14(1):56- 64.
  • 4Clark AJ,Ahmedzai SH.Efficacy and safety of oral controlled-release morphine andsustained-release oral morphine in patients with cancer and chronic noncallcer pain[J].Current Medical Research and Opimon, 2004,20(9):1419-1428.
  • 5郭静波,魏丽萍,王玉梅.芬太尼透皮贴剂与口服吗啡控释片治疗国人中重度癌痛临床效果的Meta分析[J].中国卫生统计,2010,27(4):385-387. 被引量:36
  • 6邵月娟,王昆,成宪江,穆怀焕.44例晚期癌痛患者口服吗啡转换为芬太尼贴剂的疗效分析[J].中国疼痛医学杂志,2008,14(6):335-337. 被引量:8
  • 7赵月霞,黄丽娟.芬太尼透皮贴剂与口服吗啡控释片治疗老年中重度癌痛疗效比较[J].临床和实验医学杂志,2008,7(12):31-32. 被引量:7
  • 8Portenoy RK,Southam MA,Gupta SK,et al.Oral controlled-release mor- phine for cancer pain-repeated dose pharmacokinetics[J].Anesthesiolgy,1993,78(1):36-43.
  • 9Smith MJ,Watt JA,Cramond T.Morphine-3-glueuronide-a potent antag- onist of morphine analgesia[J].lAfe Sci,1990,47(6):579-585.
  • 10Herbst LH,Stranse LG.Transdermal fantanyl use in hospice home-care patients with chronic cancer pain[J].J Pain Syndrome Manage,1992,7 (Suppl):54-57.

二级参考文献31

共引文献45

同被引文献119

引证文献16

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部